US2019374715A1PendingUtilityA1

Drug delivery systems and methods

Assignee: ALCYONE LIFESCIENCES INCPriority: May 11, 2015Filed: Aug 21, 2019Published: Dec 12, 2019
Est. expiryMay 11, 2035(~8.8 yrs left)· nominal 20-yr term from priority
A61M 2230/005A61M 2210/1003A61M 2202/0464A61M 5/1723A61M 2210/0687
60
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Drug delivery systems and methods are disclosed herein. In some embodiments, a drug delivery system can be configured to deliver a drug to a patient in coordination with a physiological parameter of the patient (e.g., the patient's natural cerebrospinal fluid (CSF) pulsation or the patient's heart or respiration rate). In some embodiments, a drug delivery system can be configured to use a combination of infusion and aspiration to control delivery of a drug to a patient. Catheters, controllers, and other components for use in the above systems are also disclosed, as are various methods of using such systems.

Claims

exact text as granted — not AI-modified
1 .- 69 . (canceled) 
     
     
         70 . A method of delivering a drug to a patient, the method comprising:
 inserting a delivery device into an intrathecal space of the patient;   measuring a natural intrathecal pulsation and a cardiac rate of the patient;   determining a correlation between the natural intrathecal pulsation and the cardiac rate of the patient; and   infusing a drug through the delivery device and into the intrathecal space based on an estimated intrathecal pulsation based on a measured cardiac rate during infusion, wherein the drug is infused in a pulsatile manner.

Join the waitlist — get patent alerts

Track US2019374715A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.